Renaissance Technologies’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.47M Sell
489,460
-125,640
-20% -$1.05M 0.01% 1441
2025
Q4
$4.58M Sell
615,100
-196,100
-24% -$1.41M 0.01% 1361
2025
Q3
$5.43M Buy
811,200
+20,382
+3% +$141K 0.01% 1443
2025
Q2
$5.24M Buy
790,818
+237,318
+43% +$1.68M 0.01% 1495
2025
Q1
$5.06M Buy
553,500
+164,800
+42% +$1.65M 0.01% 1424
2024
Q4
$4.08M Buy
388,700
+800
+0.2% +$9.46K 0.01% 1579
2024
Q3
$4.64M Sell
387,900
-115,275
-23% -$997K 0.01% 1490
2024
Q2
$2.89M Buy
503,175
+402,841
+401% +$2.21M ﹤0.01% 1636
2024
Q1
$522K Sell
100,334
-34,911
-26% -$171K ﹤0.01% 2844
2023
Q4
$713K Buy
135,245
+55,445
+69% +$219K ﹤0.01% 2592
2023
Q3
$263K Buy
+79,800
New +$280K ﹤0.01% 2992
2021
Q4
Sell
-23,900
Closed -$338K 3911
2021
Q3
$338K Sell
23,900
-62,100
-72% -$956K ﹤0.01% 3040
2021
Q2
$1.51M Buy
+86,000
New +$1.39M ﹤0.01% 2433

Other funds holding BVS